Journal of the American Chemical Society
which is readily prepared on 30 g scale in a single pass.
Page 14 of 16
S10OD023532. We thank Dr. Kathleen Durkin and Dr. Yinka
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
Olatunji-Ojo for assistance with DFT calculations and Dr. An-
tonio DiPasquale and Nicholas Settineri for single crystal X-
ray diffraction studies.
Advanced intermediate 60 is common to the synthesis of
these natural products and is prepared on multigram scale
per run. We have also developed a gram-scale enantiose-
lective approach to 13 that should allow for the prepara-
tion of enantioenriched natural products. In doing so, we
discovered a bismuth-catalyzed methanolysis of imide 113
that exclusively targets the more sterically-encumbered
carbonyl. Motivated by the effectiveness of this network
analysis approach, we have developed a freely accessible
web-based program, that facilitates quick and accurate
application of this concept by anyone in the synthetic
community designing retrosyntheses.
REFERENCES
(1) Atta-ur-Rahman; Choudhary, M. I. Nat. Prod. Rep. 1999, 16,
619.
(
2) Wang, F.-P.; Chen, Q.-H.; Liu, X.-Y. Nat. Prod. Rep. 2010, 27,
5
29.
(
(
3) Wang, X.-W.; Xie, H. Drugs Future 1999, 24, 877.
4) Sun, J.; Peng, Y.; Wu, H.; Zhang, X.; Zhong, Y.; Xiao, Y.; Zhang,
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
F.; Qi, H.; Shang, L.; Zhu, J.; Sun, Y.; Liu, K.; Liu, J.; A, J.; Ho, R. J. Y.;
Wang, G. Drug Metab. Dispos. 2015, 43, 713.
(
5) The C18-Diterpenoid Alkaloids. In The Alkaloids: Chemistry
ASSOCIATED CONTENT
Supporting Information.
This material is available free of charge via the Internet at
http://pubs.acs.org.
and Biology; Cordell, G. A., Ed.; Academic Press: San Diego, 2009;
Vol. 67, pp 1‒78.
(
(
K.; Aoki, H.; Takahashi, K.; Endo, S. J. Anal. Toxicol. 2007, 31, 132.
(8) Stevens, M.; Peigneur, S.; Tytgat, J. Front. Pharmacol. 2011,
6) Ameri, A. Prog. Neurobiol. 1998, 56, 211.
7) Fujita, Y.; Terui, K.; Fujita, M.; Kakizaki, A.; Sato, N.; Oikawa,
Crystallographic data for 34
Crystallographic data for 35
Crystallographic data for 36
Crystallographic data for 44
2
, 71.
9) Borcsa, B.; Fodor, L.; Csupor, D.; Forgo, P.; Molnár, A., V;
Hohmann, J. Planta Med. 2014, 80, 231.
10) Wang, F.-P.; Chen, Q.-H. The C19-Diterpenoid Alkaloids. In
(
Crystallographic data for 47
(
Crystallographic data for endo-108
Experimental procedures, characterization data for new
compounds and the natural products, density functional
theory energies and geometries
The Alkaloids: Chemistry and Biology; Cordell, G. A., Ed.; Academic
Press: San Diego, 2010; Vol. 69, pp 1‒577.
(11) Wang, F.-P.; Liang, X.-T. C20-Diterpenoid Alkaloids. In The
Alkaloids: Chemistry and Biology; Cordell, G. A., Ed. Academic
Press: San Diego, 2002; Vol. 59, pp 1‒280.
(
12) Marth, C. J.; Gallego, G. M.; Lee, J. C.; Lebold, T. P.; Kulyk, S.;
AUTHOR INFORMATION
Corresponding Author
Kou, K. G. M.; Qin, J.; Lilien, R.; Sarpong, R. Nature 2015, 528, 493.
(13) Kou, K. G. M.; Li, B. X.; Lee, J. C.; Gallego, G. M.; Lebold, T. P.;
DiPasquale, A. G.; Sarpong, R. J. Am. Chem. Soc. 2016, 138, 10830.
(14) Pelletier, S. W.; Parthasarathy, P. C. Tetrahedron Lett.
*rsarpong@berkeley.edu
1
963, 4, 205.
Present Addresses
Theravance Biopharma US, Inc., 901 Gateway Boulevard,
(
15) For early formal syntheses of atisine, see: (a) Nagata, W.;
†
Sugasawa, T.; Narisada, M.; Wakabayashi, T.; Hayase, Y. J. Am.
Chem. Soc. 1963, 85, 2342. (b) Nagata, W.; Sugasawa, T.; Narisada,
M.; Wakabayashi, T.; Hayase, Y. J. Am. Chem. Soc. 1967, 89, 1483.
(c) Masamune, S. J. Am. Chem. Soc. 1964, 86, 291. (d) Guthrie, R.
W.; Valenta, Z.; Wiesner, K. Tetrahedron Lett. 1966, 7, 4645.
(16) Masamune, S. J. Am. Chem. Soc. 1964, 86, 290.
(17) (a) Nagata, W.; Narisada, M.; Wakabayashi, T.; Sugasawa,
T. J. Am. Chem. Soc. 1964, 86, 929. (b) Nagata, W.; Narisada, M.;
Wakabayashi, T.; Sugasawa, T. J. Am. Chem. Soc. 1967, 89, 1499.
(18) (a) Wiesner, K.; Uyeo, S.; Philipp, A.; Valenta, Z. Tetrahe-
dron Lett. 1968, 9, 6279. (b) Wiesner, K.; Komlossy, Z. I.; Philipp,
A.; Valenta, Z. Experientia 1970, 26, 471.
South San Francisco, CA 94080, USA
‡
th
The University of Chicago Law School, 1111 East 60 Street,
Chicago, IL 60637, USA
§
World Wide Medicinal Chemistry, Groton Laboratories, Pfiz-
er, Inc., Eastern Point Road, Groton, CT 06340, USA
¶
Department of Chemistry, Pfizer Pharmaceuticals, La Jolla
Laboratories, 10770 Science Center Drive, La Jolla, CA 92121,
USA
‖
Janssen Research & Development, LLC, 3210 Merryfield Row,
San Diego, CA 92121-1126, USA
(
19) For a review on the total syntheses of diterpenoid alka-
loids, see: Zhu, G.; Liu, R.; Liu, B. Synthesis 2015, 47, 2691.
20) For a review on the use of the oxidative dearomatiza-
Notes
The authors declare no competing financial interest.
(
tion/Diels‒Alder cycloaddition sequence for the synthesis of
diterpenes and diterpenoid alkaloids, see: Liu, X.-Y.; Qin, Y. Nat.
Prod. Rep. 2017, Advance Article, doi: 10.1039/C7NP00033B.
ACKNOWLEDGMENT
This project is supported by Award No. R01 GM084906 from
the National Institute of General Medical Sciences. K.G.M.K.
and T.P.L. thanks NSERC for post-doctoral fellowships. We are
grateful to the NSF GRFP for graduate fellowships to C.J.M. and
N.A.D. (DGE 1106400). G.M.G. acknowledges the NIH
(5F31GM095238) for a graduate fellowship. X-ray crystallog-
raphy instrumentation are supported by NIH Shared Instru-
mentation Grant S10-RR027172. The AV-600, AV-500, DRX-
(
21) Cherney, E. C.; Lopchuk, J. M.; Green, J. C.; Baran, P. S. J. Am.
Chem. Soc. 2014, 136, 12592.
22) Cheng, H.; Zeng, F.-H.; Yang, X.; Meng, Y.-J.; Xu, L.; Wang, F.
P. Angew. Chem., Int. Ed. 2016, 55, 392.
23) Hamlin, A. M.; Cortez, F. de J.; Lapointe, D.; Sarpong, R. An-
(
(
gew. Chem., Int. Ed. 2013, 52, 4854.
(24) Hamlin, A. M.; Lapointe, D.; Owens, K.; Sarpong, R. J. Org.
Chem. 2014, 79, 6783.
(25) Nishiyama, Y.; Han-ya, Y.; Yokoshima, S.; Fukuyama, T. J.
Am. Chem. Soc. 2014, 136, 6598.
(26) Nishiyama, Y.; Yokoshima, S.; Fukuyama, T. Org. Lett.
2016, 18, 2359.
(27) Corey, E. J.; Howe, W. J.; Orf, H. W.; Pensak, D. A.; Petersson,
G. J. Am. Chem. Soc. 1975, 97, 6116.
5
00, AVQ-400, and AVB-400 NMR spectrometers are partially
supported by NIH Grants SRR023679A and 1S10RR016634-
1 and NSF Grants CHE-9633007 and CHE-0130862. The 900
0
MHz NMR instrument is funded by NIH Grant GM68933. The
Molecular Graphics and Computation Facility is funded by NIH
ACS Paragon Plus Environment